Qilu Pharmaceutical Achieved Staggering Sales of Bevacizumab of RMB1.8 Billion in 2020
According to industry news, Qilu Pharmaceutical achieved sales of bevacizumab (trade name: Ankeda) of about RMB1.8 billion in 2020.
March 4, 2021
by PharmaSources/Caicai
Samsung Biologics Reports 66% Increase in 2020 Revenue Achieving "1 Trillion Won" Target Sales
Samsung Biologics reported its fourth quarter and full-year 2020 financial results indicating strong business performance, benefitting from increased sales across all plants and significant business agility and operating excellence in overcoming ...
January 26, 2021
by prnasia
Jan Aushadi Kendras record sales of Rs 484 crores in FY 2020-2021
This figure is 60 per cent higher than the corresponding figures of the previous financial year and has led to savings of approximately Rs 3000 crores to the citizens of this country, announced Sadananda Gowda.
January 15, 2021
by expresspharma
BPPI records sales turnover of Rs 146.59 cr in first quarter of 2020-21
BPPI, the implementing agency of Pradhanmantri Janaushadhi Pariyojana-PMBJP, clocked a sales turnover of Rs. 146.59 crores in the first quarter of 2020-21 as compared to Rs 75.48 crore achieved in the first quarter of 2019-20.
September 7, 2020
by expresspharma
Morepen Labs clocks double-digit growth in its sales and net profit in FY 2019-20
Consolidated Profit before Tax (PBT) recorded extraordinary growth by 34 per cent at Rs. 39.11 crore, up from Rs. 29.18 crore in the previous fiscal.
June 24, 2020
by expresspharma
LANXESS robust in first quarter of 2020 despite coronavirus crisis
Sales down only slightly year-on-year at EUR 1.704 billion.
May 8, 2020
by expresspharma